Association of PTEN Gene SNPs rs2299939 With PFS in Patients With Small Cell Lung Cancer Treated With Early Radiotherapy.

PFS PTEN SCLC radio-chemotherapy rs2299939

Journal

Frontiers in genetics
ISSN: 1664-8021
Titre abrégé: Front Genet
Pays: Switzerland
ID NLM: 101560621

Informations de publication

Date de publication:
2020
Historique:
received: 23 10 2019
accepted: 13 03 2020
entrez: 12 5 2020
pubmed: 12 5 2020
medline: 12 5 2020
Statut: epublish

Résumé

Lung cancer has higher morbidity and mortality than most cancers. It is common that there are some phenomenons of secondary drug resistance, radiotherapy resistance and poor prognosis during the treatment of small cell lung cancer (SCLC). Recent studies revealed that the single-nucleotide polymorphisms (SNPs) are associated with the curative effect among patients with the same pathological type and stage. Our study analyzed the start time of radiotherapy and the relationship between PTEN gene rs2299939 polymorphisms and survival time among 116 SCLC patients. The results showed that early radiotherapy significantly improved the time of survival in patients compared with late radiotherapy (

Identifiants

pubmed: 32391045
doi: 10.3389/fgene.2020.00298
pmc: PMC7190978
doi:

Types de publication

Journal Article

Langues

eng

Pagination

298

Informations de copyright

Copyright © 2020 Wang, Yang, Zhang, Zhang, Yang, Wang, Zhou, Li, Li, Nie and Li.

Références

Hum Mol Genet. 2010 Dec 15;19(24):4948-54
pubmed: 20876614
Cancer Radiother. 2016 Oct;20(6-7):547-57
pubmed: 27614522
Br J Cancer. 2013 Apr 30;108(8):1695-703
pubmed: 23549037
Chin Med J (Engl). 2015 Apr 20;128(8):1005-13
pubmed: 25881591
Clin Transl Oncol. 2013 Dec;15(12):985-90
pubmed: 24005836
Medicine (Baltimore). 2017 Dec;96(49):e8994
pubmed: 29245274
Chest. 2012 Dec;142(6):1620-1635
pubmed: 23208335
Ann Oncol. 2013 Oct;24 Suppl 6:vi99-105
pubmed: 23813929
J Thorac Oncol. 2011 Jan;6(1):183-9
pubmed: 21107291
Clin Respir J. 2016 Nov;10(6):681-683
pubmed: 25620524
J Clin Oncol. 2010 Nov 20;28(33):4945-52
pubmed: 20940192
Semin Surg Oncol. 2003;21(3):176-81
pubmed: 14508850
Carcinogenesis. 2006 Dec;27(12):2448-54
pubmed: 16774934
Clin Cancer Res. 2014 Jun 15;20(12):3272-9
pubmed: 24737549
J Natl Compr Canc Netw. 2018 Oct;16(10):1171-1182
pubmed: 30323087
Lung Cancer. 2013 Jan;79(1):14-9
pubmed: 23153659
Int J Clin Exp Pathol. 2015 Nov 01;8(11):15198-203
pubmed: 26823866
Sci Rep. 2016 Jun 01;6:26526
pubmed: 27246533
Mol Cancer Res. 2014 May;12(5):654-9
pubmed: 24482365
Med Oncol. 2014 Dec;31(12):333
pubmed: 25416047
Mol Neurobiol. 2017 Aug;54(6):4150-4159
pubmed: 27324896
Mutagenesis. 2015 Nov;30(6):771-84
pubmed: 25976910
Cancer Invest. 2012 May;30(4):317-22
pubmed: 22468780
Cancer Treat Rev. 2013 Aug;39(5):498-506
pubmed: 23084098
J Chemother. 2010 Jun;22(3):191-6
pubmed: 20566425
Lung Cancer. 2012 Jan;75(1):102-9
pubmed: 21676483
Cancer Treat Rev. 2007 Aug;33(5):461-73
pubmed: 17513057
Pharmacogenomics J. 2013 Oct;13(5):417-22
pubmed: 22664479
Zhonghua Zhong Liu Za Zhi. 2019 Feb 23;41(2):112-117
pubmed: 30862140
Semin Respir Crit Care Med. 2016 Oct;37(5):783-796
pubmed: 27732999
Lancet. 2005 Oct 15-21;366(9494):1385-96
pubmed: 16226617
Pharmacogenomics J. 2014 Feb;14(1):20-7
pubmed: 23478653
Ann Surg Oncol. 2015 Feb;22(2):630-5
pubmed: 25145502
Cancer. 2015 Mar 1;121(5):664-72
pubmed: 25336398
Zhonghua Zhong Liu Za Zhi. 2016 Jul;38(7):504-9
pubmed: 27531263
Lancet. 2011 Nov 12;378(9804):1741-55
pubmed: 21565397
Semin Cancer Biol. 2015 Dec;35:180-90
pubmed: 26192967
J Thorac Oncol. 2011 Jan;6(1):132-8
pubmed: 21079520
Ann Oncol. 2010 Oct;21(10):2011-6
pubmed: 20439344
J Clin Oncol. 2004 Dec 1;22(23):4837-45
pubmed: 15570087
Nat Rev Cancer. 2008 Mar;8(3):193-204
pubmed: 18256616
Mol Oncol. 2019 Feb;13(2):290-306
pubmed: 30422399
Clin Lung Cancer. 2017 Mar;18(2):178-188.e4
pubmed: 27908619
Carcinogenesis. 2013 Feb;34(2):307-13
pubmed: 23144319
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
Mol Biol Rep. 2018 Jun;45(3):253-261
pubmed: 29397516
Cancer Sci. 2012 Aug;103(8):1451-9
pubmed: 22568453
Clin Cancer Res. 2017 Dec 15;23(24):7550-7557
pubmed: 28974547

Auteurs

Chunbo Wang (C)

Department of Radiotherapy, The Third Affiliated Hospital of Harbin Medical University, Harbin, China.
School of Life Sciences and Technology, Harbin Institute of Technology, Harbin, China.

Depeng Yang (D)

School of Life Sciences and Technology, Harbin Institute of Technology, Harbin, China.

Xiaoqing Zhang (X)

School of Life Sciences and Technology, Harbin Institute of Technology, Harbin, China.

Xiaohan Zhang (X)

School of Life Sciences and Technology, Harbin Institute of Technology, Harbin, China.

Lijun Yang (L)

School of Life Sciences and Technology, Harbin Institute of Technology, Harbin, China.

Pingping Wang (P)

School of Life Sciences and Technology, Harbin Institute of Technology, Harbin, China.

Wenyang Zhou (W)

School of Life Sciences and Technology, Harbin Institute of Technology, Harbin, China.

Huaxin Li (H)

School of Life Sciences and Technology, Harbin Institute of Technology, Harbin, China.

Yiqun Li (Y)

School of Life Sciences and Technology, Harbin Institute of Technology, Harbin, China.

Huan Nie (H)

School of Life Sciences and Technology, Harbin Institute of Technology, Harbin, China.

Yu Li (Y)

School of Life Sciences and Technology, Harbin Institute of Technology, Harbin, China.

Classifications MeSH